当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:526.02亿  总市值:663.29亿
流通股本:21.18亿   总股本:26.71亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润35.12亿元,每股收益1.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益5993372.89万元,未分配利润2655305.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产11746056.73万元,负债5752683.84万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入41,067,195,862.5930,911,889,002.920,462,812,731.1510,157,255,262.4
营业总成本39,397,511,520.6429,362,812,762.8519,408,879,676.269,522,433,489.91
营业利润4,245,103,909.313,107,588,817.821,929,286,791.651,021,364,060.98
利润总额4,169,281,679.723,071,565,885.41,931,200,793.341,018,423,857.09
净利润3,512,440,3852,518,517,637.461,549,731,977.11786,221,155.86
其他综合收益43,142,250.33-213,927,299.31112,419,919.1891,154,209.97
综合收益总额3,555,582,635.332,304,590,338.151,662,151,896.29877,375,365.83
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计34,491,060,582.7334,527,299,352.0534,797,913,650.7533,839,364,765.22
非流动资产合计82,969,506,766.5480,737,462,405.0980,739,900,515.1479,906,424,660.39
资产总计117,460,567,349.27115,264,761,757.14115,537,814,165.89113,745,789,425.61
流动负债合计37,452,669,252.7937,517,582,094.3737,401,861,771.4433,602,092,132.74
非流动负债合计20,074,169,184.1618,552,575,493.1419,274,010,769.3922,608,023,220.39
负债合计57,526,838,436.9556,070,157,587.5156,675,872,540.8356,210,115,353.13
归属于母公司股东权益合计47,261,106,860.7347,301,473,095.2446,967,200,004.1446,345,852,168.62
股东权益合计59,933,728,912.3259,194,604,169.6358,861,941,625.0657,535,674,072.48
负债和股东权益合计117,460,567,349.27115,264,761,757.14115,537,814,165.89113,745,789,425.61
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计43,172,147,821.7731,551,927,328.3920,745,072,818.2210,300,650,067.68
经营活动现金流出小计38,695,166,559.5528,565,289,973.2218,838,068,920.229,383,337,962.65
经营活动产生的现金流量净额4,476,981,262.222,986,637,355.171,907,003,898917,312,105.03
投资活动现金流入小计2,405,322,190.851,823,762,368.12516,001,223.51376,935,106.13
投资活动现金流出小计6,018,645,562.074,263,474,836.993,165,950,137.691,568,066,271.67
投资活动产生的现金流量净额-3,613,323,371.22-2,439,712,468.87-2,649,948,914.18-1,191,131,165.54
筹资活动现金流入小计33,369,274,946.323,965,139,058.3117,913,255,802.798,178,024,612.09
筹资活动现金流出小计34,371,861,283.6624,467,428,47116,822,691,626.938,079,386,988.49
筹资活动产生的现金流量净额-1,002,586,337.36-502,289,412.691,090,564,175.8698,637,623.6
汇率变动对现金及现金等价物的影响27,989,327.43-69,635,970.1417,131,450.2123,437,769.89
现金及现金等价物净增加额-110,939,118.93-25,000,496.53364,750,609.89-151,743,667.02
期末现金及现金等价物余额9,391,449,787.119,477,388,409.519,867,139,515.939,350,645,239.02
TOP↑